Stephanie Labonville

Recent Posts

Voluntary Removal of Opioid Opana ER from the Market

Posted by Stephanie Labonville on Aug 2, 2017 8:00:00 AM

Endo Pharmaceuticals Inc. recently released news that it will voluntarily remove Opana ER from the market, with planned shipments slated to end September 1, 2017.  This news follows the Food and Drug Administration’s (FDA) June 2017 request to withdraw Opana ER from the market due to risks related to abuse. 

Read More

Topics: Clinical

How do I Know If I'm at Risk for Opioid Abuse or Misuse?

Posted by Stephanie Labonville on Jul 6, 2017 10:12:06 AM

With opioid abuse and misuse so prevalent today, it is important to understand the scale of the issue and be aware that certain factors might put you or someone you know at risk for developing opioid addiction, abuse, harm or misuse. 

Read More

Topics: Clinical, Pain Management

How to Manage Pain After Surgery

Posted by Stephanie Labonville on Jun 22, 2017 9:55:45 AM

The International Association for the Study of Pain (IASP) has named 2017 the Global Year Against Pain After Surgery. Anyone who is undergoing surgery wants the process to be as smooth and painless as possible, and the IASP has dedicated this year towards promoting better pain management after surgery, with efforts targeting both healthcare professionals and patients.

Read More

Topics: Pain Management

Is Pain All in My Head?

Posted by Stephanie Labonville on May 30, 2017 2:29:30 PM

Pain is the result of signals sent to and interpreted by your brain.  Pain signals can come from many areas of your body, but you do not know you’re in pain until your brain processes and perceives it.  Though the perception of pain is generally initiated once there is an injury (which causes pain signals to be sent to the brain), sometimes even after an injury has healed, the brain still perceives the existence of pain.

Read More

Topics: Pain Management

Topical Compound Medications: An Alternative to Oral Medications

Posted by Stephanie Labonville on May 11, 2017 8:00:00 AM

Topical compound medications are typically not the first choice for treatment of pain from a workplace injury, but they can be useful in some situations.

Read More

Topics: Clinical, Pain Management

Generic vs. Brand: What's the Difference?

Posted by Stephanie Labonville on Apr 19, 2017 8:00:00 AM

According to the FDA, nearly 8 in 10 prescriptions filled in the United States are for generic drugs.  That statistic may lead to the question, what are generic drugs and why are they apparently used more often than brand drugs?  To answer that question, it is important to understand a little bit about how drugs are developed and come to market. 

Read More

Topics: Clinical

New Treatment Guideline Recommendations for Low Back Pain

Posted by Stephanie Labonville on Apr 11, 2017 8:30:00 AM

The American College of Physicians recently released new clinical practice guidelines that recommend non-drug therapies as the first place to start when treating low back pain.  Whether the low back pain is acute (lasting less than 4 weeks), subacute (4-12 weeks), or chronic (lasting more than 12 weeks), clinicians and patients should not initially select medications alone to improve low back pain and function.

Read More

Topics: Pain Management

Opiate, Opioid, Narcotic - What's the Difference?

Posted by Stephanie Labonville on Mar 29, 2017 8:00:00 AM

The terms opiate, opioid and narcotic are often used in what would seem the same way. With prescription pain medications reaching their highest point in years, it’s wise to know the difference between each of these terms and how they work.

Read More

Topics: Clinical

Top 8 Pain Management Videos to Watch

Posted by Stephanie Labonville on Mar 8, 2017 8:00:00 AM

Pain is something that about 1 out of every 4 people in the United States deals with on a daily basis. According to the American Academy of Pain Medicine, pain affects more Americans than diabetes, heart disease and cancer combined. 

Read More

Topics: Pain Management

Are Tamper Resistant Drugs a Way to Curb the Opioid Epidemic?

Posted by Stephanie Labonville on Feb 23, 2017 8:00:00 AM

Tamper resistant and abuse deterrent opioid formulations are designed to make drugs difficult or less desirable to use in any manner other than how they were prescribed.  The formulations make them harder to crush, chew, cut, dissolve, inhale, inject, or less rewarding if done so, thus deterring use in many of the ways they are abused.   With the goal of combatting the opioid epidemic, the “FDA is encouraging the development of opioid formulations with abuse-deterrent properties”.

Read More

Topics: Clinical, Pain Management

Blog Subscription

Peace of Mind, Delivered.

IWP is a specialized workers' compensation pharmacy service that delivers prescription medications directly to the doorstep of injured individuals nationwide.